PMID: 6110874Mar 21, 1981Paper

C-reactive protein fifty years on

Lancet
M B Pepys

Abstract

The discovery of C-reactive protein (CRP) half a century ago led to the description of the acute-phase reaction which is a fundamental response of the body to injury. Recent work on the structure and function of CRP has revealed the existence of a unique plasma protein family, including CRP and serum amyloid P component (SAP). These proteins have been conserved throughout vertebrate evolution. CRP binds specifically to a wide range of substances derived both from damaged autologous cells and from microorganisms. Complexed CRP can activate the complement system and, by virtue of its dramatically increased production in response to tissue injury, it probably acts primarily as a protective mechanism. However, in some circumstances CRP may also initiate or exacerbate inflammatory lesions. Clinical measurement of serum CRP is valuable as a screening test for organic disease and as a sensitive object index of disease activity and response to therapy in some inflammatory, infective, and ischaemic conditions. SAP closely resembles CRP in structure but not an acute-phase reactant in man. An apparently identical protein, amyloid P component (AP), is always found in amyloid deposits. AP is also found in normal tissues, as an integral cons...Continue Reading

References

Oct 1, 1979·Molecular Immunology·N R Cooper, R J Ziccardi
Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·E B OliveiraT Y Liu
Dec 1, 1979·Journal of Clinical Pathology·P H MackieJ Stuart
May 1, 1978·The Journal of Clinical Investigation·R C WilliamsZ H Abdin
Jun 1, 1977·Arthritis and Rheumatism·S HonigG Weissmann
Jul 1, 1975·Proceedings of the Society for Experimental Biology and Medicine·C R MerrimanR F Kampschmidt
Apr 1, 1972·Carbohydrate Research·M HeidelbergerJ D Higginbotham
Feb 1, 1966·The Journal of Experimental Medicine·J HurlimannG M Hochwald
Feb 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·J E Volanakis, M H Kaplan
Feb 8, 1980·Molecular and Cellular Biochemistry·E PearlsteinA Garcia-Pardo
Nov 1, 1980·The Journal of Experimental Medicine·R F DyckM B Pepys
Feb 1, 1980·Annals of the Rheumatic Diseases·P CowlingA Ebringer
Aug 1, 1964·Clinica Chimica Acta; International Journal of Clinical Chemistry·A FRENSDORFFE SOHAR
Mar 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·E C Gotschlich, G M Edelman
Sep 30, 1930·The Journal of Experimental Medicine·W S Tillett, T Francis
Jan 1, 1937·The Journal of Experimental Medicine·T J Abernethy, T Francis

❮ Previous
Next ❯

Citations

Jan 1, 1988·Veterinary Research Communications·P D Eckersall, J G Conner
Jan 1, 1987·Archives of Gynecology and Obstetrics·M HemiläO Ylikorkala
Sep 1, 1997·Pediatric Surgery International·H W GrantT Doorasamy
Feb 1, 1987·Digestive Diseases and Sciences·J P WrightN Tigler-Wybrandi
Jan 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P C LigtenbergJ Verhoef
Jun 15, 1989·Experientia·A Agrawal, S Bhattacharya
Jan 1, 1986·Clinical Rheumatology·L F LinaresI Ibero
Sep 1, 1988·Clinical Rheumatology·T D Spector, D L Scott
Jan 1, 1990·Archives of Gynecology and Obstetrics·T KurkiJ Paavonen
Jun 1, 1990·Cardiovascular and Interventional Radiology·D J Allison, A Booth
Jan 1, 1996·Indian Journal of Pediatrics·H K PemdeK M Belapurkar
Dec 1, 1984·Irish Journal of Medical Science·J P LavelleM C Neligan
Oct 14, 2004·Der Orthopäde·J Jerosch
May 13, 2006·Glycoconjugate Journal·Waliza AnsarChitra Mandal
Aug 28, 2013·Current Treatment Options in Cardiovascular Medicine·Mahesh J Patel, Michael A Blazing
Feb 23, 2012·Biological Trace Element Research·Vinh Q BuiReynaldo Martorell
Mar 7, 2012·Journal of Molecular Neuroscience : MN·Hung HsuchouWeihong Pan
Sep 28, 2013·Molecular Diagnosis & Therapy·Johannes Mair, Allan S Jaffe
Feb 1, 1987·American Journal of Obstetrics and Gynecology·J M ErnestP J Meis
Nov 25, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·B ShineM B Pepys
Nov 29, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·I Das
May 30, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·B ShineJ Landon
May 15, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·G HulmanP R Bell
May 29, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·G Hulman, M Fuller
Sep 30, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·W Y Craig, T B Ledue
Oct 29, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·T D PongS L Cottin
Dec 31, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·T B LedueW Y Craig
Nov 15, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·A BourguignatI Kempf
Jan 1, 1992·Injury·P Gosling, G R Dickson
Jan 1, 1982·Journal of Immunological Methods·F C De Beer, M B Pepys
Jan 1, 1982·Journal of Immunological Methods·E M Salonen
Jan 1, 1982·Journal of Immunological Methods·F C De Beer, M B Pepys
Jun 8, 1984·Journal of Immunological Methods·R D NargessiJ Landon
Apr 27, 1984·Journal of Immunological Methods·M A GertzR A Kyle
Aug 1, 1992·Journal of the Neurological Sciences·P Berlit
Oct 1, 1983·Gynecologic Oncology·J H MeerwaldtM E v d Burg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.